FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060496 [Registered on: 04/12/2023] Trial Registered Prospectively
Last Modified On: 09/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Jaloukavacharana(medicinal leech therapy)]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to compare medicinal leech therapy( jaloukavacharana) versus drug gugguluthikthaka taila combined with medicinal leech therapy in lower extremity peripheral arterial disease associated with type 2 diabetes mellitus 
Scientific Title of Study   Efficacy of gugguluthikthaka taila and jaloukavacharana in lower extremity peripheral arterial disease associated with type 2 diabetes mellitus: A Randomized controlled clinical trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Deepa Jose 
Designation  Assistant Professor 
Affiliation  Government Ayurveda College, Tripunithura 
Address  Department of Shalyatantra, Government Ayurveda College Tripunithura

Ernakulam
KERALA
682301
India 
Phone  9446864399  
Fax    
Email  jodrdeepa@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sreeja Sukesan 
Designation  Professor and HOD 
Affiliation  Government Ayurveda College, Tripunithura 
Address  Department of Shalakyatantra, Government Ayurveda College Tripunithura

Ernakulam
KERALA
682301
India 
Phone  7034115701  
Fax    
Email  doctorsreejamd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sreeja Sukesan 
Designation  Professor and HOD 
Affiliation  Government Ayurveda College, Tripunithura 
Address  Department of Shalakyatantra, Government Ayurveda College Tripunithura

Ernakulam
KERALA
682301
India 
Phone  7034115701  
Fax    
Email  doctorsreejamd@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda College,Tripunithura,Ernakulam  
 
Primary Sponsor  
Name  Dr.Deepa Jose 
Address  Assistant Professor Department of Shalyatantra Government Ayurveda College,Tripunithura,Ernakulam 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrDeepa Jose  Government Ayurveda College Hospital,Tripunithura  O.P.Room no.4,Department of Shalyatantra, Government Ayurveda College Hospital, Tripunithura Pin -682301
Ernakulam
KERALA 
9446864399

jodrdeepa@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Committee For Ethics in Research , Govt. Ayurveda College, Tripunithura  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I702||Atherosclerosis of native arteriesof the extremities,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gugguluthikthaka Taila, Reference: Chikitsa manjari and Ashtanga Hridaya, Route: Oral, Dosage Form: Taila, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Intervention ArmProcedure-jalaukAvacaraNam, जलौकावचरणम् (Procedure Reference: Susruta Samhita, Procedure details: intervention 2 -: Bloodletting with medicinal leech. Numbers of bloodletting : 7 nos. Interval of bloodletting : 7days. Site of leech application : Distal ½ of leg & foot in PAD affected lower limb. Days of bloodletting : 1st, 7th, 14th, 21th, 28th, 35th, 42nd days of study period. )
3Comparator ArmProcedure-jalaukAvacaraNam, जलौकावचरणम् (Procedure Reference: Susruta samhita, Procedure details: Procedure details: Control intervention -: Bloodletting with medicinal leech. Numbers of bloodletting : 7 nos. Interval of bloodletting : 7days. Site of leech application : Distal ½ of leg & foot in PAD affected lower limb. Days of bloodletting : 1st, 7th, 14th, 21th, 28th, 35th, 42nd days of study period. ))
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1. LE-PAD in known T2DM patients diagnosed by clinical examination and colour Doppler study of lower limb arteries.
2. IC due to unilateral or bilateral PAD (Rutherford 1-3) or Rutherford category 0 with atherosclerotic plaques in either femoropopliteal or below popliteal arteries in arterial Doppler study.
3. Age group 40-75 years
4. Atherosclerosis of femoropopliteal and below popliteal arteries in colour Doppler study.
5. Informed written consent

 
 
ExclusionCriteria 
Details  1. Advanced PAD beyond IC (rest pain, ulcer, gangrene, Rutherford 4-6)
2. Prior revascularization in lower extremities in previous 12 months.
3. Neurogenic/venous/orthopedic claudication more dominant than arterial.
2. Acute PAD
3. Buerger’s disease
4. Known cases of Diabetic nephropathy, liver disease, cancer, obesity
5. Contra indication of snehana
6. Cardiac failure
7. Uncontrolled hypertension

 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in 6 – minutes walking distance (6MWD)   Measurement of 6 – minutes walking distance (6MWD) - 0th, 45th and 61st days of study period.  
 
Secondary Outcome  
Outcome  TimePoints 
1.Rutherford clinical classification of PAD
2. Colour doppler study of arterial system of affected lower extremities
3. Total Cholesterol, Triglycerides, LDL, HDL, S.Creatinine, Hb,ESR, FBS, PPBS and HbA1C levels 
1.Rutherford clinical classification of PAD - 0th, 45th & 61 days
2. Colour doppler study of arterial system of affected lower extremities - before & after study
3. Total Cholesterol,Triglycerides, LDL, HDL, S.Creatinine, Hb,ESR, FBS, PPBS and HbA1C levels - 0th & 61 days 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   04/12/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized, parallel group single centre trial comparing the efficacy of Gugguluthikthaka taila 15ml bid daily for 60 days  combined with Jaloukavacharana ( Medicinal leech therapy) 7times at 7days interval in intervention arm and Jaloukavacharana (Medicinal leech therapy) 7times at 7days interval in control arm in 64 patients with Lower extremity peripheral arterial disease associated with type 2 diabetes mellitus, that will be conducted in single centre, at Government Ayurveda College Hospital,Tripunithura, Ernakulam,Kerala,India. This study is a part of PhD clinical research. The primary outcome measure will be 6- minutes walking distance(6MWD) assessed on 0th, 45th and 61st days of study period. The secondary outcomes will be Rutherford clinical classification of PAD assessed on 0th, 45th and 61st days , Colour doppler study of arterial system of lower extremity will de done before and after study and Total Cholesterol, LDL, HDL, Triglycerides, ESR, Serum Creatinine, Hb, FBS,PPBS and HbA1C on 0th and 61st days.
 
Close